References
Arden N, Nevitt MC. Osteoarthritis: Epidemiology. Best Pract Res Clin Rheumatol. 2006;20:3–25.
Axe JM, Snyder-Mackler L, Axe MJ. The role of viscosupplementation. Sports Med Arthrosc. 2013;21:18–22.
Balazs EA, Denlinger JL. Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9.
Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;(2):CD005321.
Bhandari M, Smith J, Miller LE, Block JE. Clinical and economic burden of revision knee arthroplasty. Clin Med Insights Arthritis Musculoskelet Disord. 2012;5:89–94.
Brockmeier SF, Shaffer BS. Viscosupplementation therapy for osteoarthritis. Sports Med Arthrosc. 2006;14:155–162.
Brown GA. AAOS clinical practice guideline: Treatment of osteoarthritis of the knee: Evidence based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:577–579.
Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH, Schunneman HJ, GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guidelines. part 1 of 3. an overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64:669–677.
Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15:1424–1436.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–6.
Feeley BT, Gallo RA, Sherman S, Williams RJ. Management of osteoarthritis of the knee in the active patient. J Am Acad Orthop Surg. 2010;18:406–411.
Goldberg VM, Coutts RD. Pseudoseptic reactions to hylan viscosupplementation: Diagnosis and treatment. Clin Orthop Relat Res. 2004;4 19:130–137.
Greenwald RA. Oxygen radicals, inflammation, and arthritis: Pathophysiological considerations and implications for treatment. Semin Arthritis Rheum. 1991;20:219–240.
Hoppe DJ, Schemitsch EH, Morshed S, Tornetta P,3rd, Bhandari M. Hierarchy of evidence: Where observational studies fit in and why we need them. J Bone Joint Surg Am. 2009;91;Suppl 3:2–9.
Keeney JA, Eunice S, Pashos G, Wright RW, Clohisy JC. What is the evidence for total knee arthroplasty in young patients? A systematic review of the literature. Clin Orthop Relat Res. 2011;469:574–583.
Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan G-F 20 (Synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg. 2002;84-A:1619–1623.
Maneiro E, de Andres MC, Fernandez-Sueiro JL, Galdo F, Blanco FJ. The biological action of hyaluronan on human osteoartritic articular chondrocytes: The importance of molecular weight. Clin Exp Rheumatol. 2004;22:307–312.
McArthur BA, Dy CJ, Fabricant PD, Valle AG. Long term safety, efficacy, and patient acceptability of hyaluronic acid injection in patients with painful osteoarthritis of the knee. Patient Prefer Adherence. 2012;6:905–910.
Mody GM, Brooks PM. Improving musculoskeletal health: Global issues. Best Pract Res Clin Rheumatol. 2012;26:237–249.
Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008;59:1207–1213.
Rutjes AW, Juni P, da Costa BR, Trelle S, Nuesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis. Ann Intern Med. 2012;157:180–191.
Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB. What is the lifetime risk of developing cancer? The effect of adjusting for multiple primaries. Br J Cancer. 2011;105:460–465.
Sedrakyan A, Paxton EW, Phillips C, Namba R, Funahashi T, Barber T, Sculco T, Padgett D, Wright T, Marinac-Dabic D. The International Consortium of Orthopaedic Registries: overview and summary. J Bone Joint Surg Am. 2011;93 Suppl 3:1–12.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.
Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE. Hyaluronic acid viscosupplementation and osteoarthritis: Current uses and future directions. Am J Sports Med. 2009;37:1636–1644.
Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: Clinical efficacy and economic implications. Drugs Aging. 2007;24:629–642.
Yelin E, Murphy L, Cisternas MG, Foreman AJ, Pasta DJ, Helmick CG. Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheum. 2007;56:1397–1340.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lomander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981–1000.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lomander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18:476–499.
Author information
Authors and Affiliations
Corresponding author
Additional information
A Note from the Editor-in-Chief: I am pleased to announce the partnership between CORR® , The Cochrane Collaboration® , and McMaster University’s Evidence-Based Orthopaedics Group for a new column, called Cochrane in CORR®. In the column, we will identify an abstract originally published in The Cochrane Library that we think is especially important, and colleagues from McMaster University will provide expert perspective on it.
(Bellamy N, Campbell J, Welch V, Gee TL, Bourne R, Wells GA. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005321. DOI: 10.1002/14651858.CD005321.pub2.)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Reproduced with permission.
The authors certify that they, or any members of their immediate family, have no funding or commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research ® editors and board members are on file with the publication and can be viewed on request.
The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR ® or the Association of Bone and Joint Surgeons®.
Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and The Cochrane Library (http://www.thecochranelibrary.com) should be consulted for the most recent version of the review.
About this article
Cite this article
Evaniew, N., Simunovic, N. & Karlsson, J. Cochrane in CORR ®: Viscosupplementation for the Treatment of Osteoarthritis of the Knee. Clin Orthop Relat Res 472, 2028–2034 (2014). https://doi.org/10.1007/s11999-013-3378-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-013-3378-8